Molecular pathways and targets in prostate cancer

Area of Science:

• Oncology
• Molecular Biology
• Urology

Background:

• Prostate cancer exhibits significant heterogeneity even in early stages.
• Deregulated androgen receptor (AR) signaling is a critical driver in most prostate tumors.
• Despite advances, 20-40% of patients relapse post-localized therapy, progressing to hormone-resistant disease.

Purpose of the Study:

• To review current knowledge on molecular pathways in localized and metastatic prostate cancer.
• To emphasize the clinical implications of recent discoveries in prostate cancer biology.
• To provide insights into the mechanisms underlying treatment resistance.

Main Methods:

• This review synthesizes existing research on prostate cancer molecular pathways.
• It analyzes data from studies on localized and advanced prostate cancer.
• Focus is placed on the role of androgen receptor signaling and resistance mechanisms.

Main Results:

• Prostate cancer initiation and progression involve unique cellular pathways.
• Androgen receptor signaling corruption leads to pleiotropic changes contributing to malignancy.
• New anti-androgen therapies improve progression-free survival but do not prevent eventual resistance.

Conclusions:

• Understanding molecular pathways is crucial for predicting prostate cancer progression.
• Further research into resistance mechanisms is vital for developing more effective treatments.
• Translating molecular insights into clinical practice can improve patient outcomes in advanced prostate cancer.